Thus, mechanisms that also effectively downregulate ERCC2 might provide a ‘tipping point’ in colon cancer cells, being unable to mount an effective DNA damage response, and triggering apoptotic or alternative cell-death pathways. The gene discussed is ERCC2; the disease is malignant colon neoplasm.